Cormorant Asset Management, LP's Form 4 filing
Bright Minds Biosciences Inc. (DRUG) · filed Oct 17, 2024
- Accession no.
- 0000929638-24-003542
- Filed
- Oct 17, 2024, 5:11 PM ET
- Trade date
- Oct 15-16, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 11 non-derivative transactions and 0 derivative transactions. Open-market purchases total $3.23M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cormorant Asset Management, LPCIK 0001583977 | 10% Owner |
| Chen BihuaCIK 0001599214 | 10% Owner |
| Cormorant Global Healthcare Master Fund, LPCIK 0001618442 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Common Shares | PPurchaseAcquired | +238,097 | $4.53 | +$1,078,674.65 | 690,506 | Indirect | |
| Oct 15, 2024 | Common Shares | PPurchaseAcquired | +63,173 | $5.92 | +$374,236.85 | 753,679 | Indirect | |
| Oct 15, 2024 | Common Shares | PPurchaseAcquired | +33,343 | $6.42 | +$214,218.77 | 787,022 | Indirect | |
| Oct 15, 2024 | Common Shares | PPurchaseAcquired | +8,900 | $7.31 | +$65,016.28 | 795,922 | Indirect | |
| Oct 15, 2024 | Common Shares | PPurchaseAcquired | +2,600 | $8.80 | +$22,890.4 | 798,522 | Indirect | |
| Oct 15, 2024 | Common Shares | PPurchaseAcquired | +2,700 | $9.26 | +$25,008.48 | 801,222 | Indirect | |
| Oct 15, 2024 | Common Shares | PPurchaseAcquired | +19,169 | $11.72 | +$224,601.26 | 820,391 | Indirect | |
| Oct 15, 2024 | Common Shares | PPurchaseAcquired | +4,609 | $12.35 | +$56,927.14 | 825,000 | Indirect | |
| Oct 16, 2024 | Common Shares | PPurchaseAcquired | +39,743 | $23.22 | +$922,633.75 | 864,743 | Indirect | |
| Oct 16, 2024 | Common Shares | PPurchaseAcquired | +7,150 | $24.03 | +$171,814.5 | 871,893 | Indirect | |
| Oct 16, 2024 | Common Shares | PPurchaseAcquired | +3,107 | $25.22 | +$78,364.75 | 875,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.